These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18186545)

  • 1. Experimental design and interaction analysis of combination studies of drugs with log-linear dose responses.
    Fang HB; Ross DD; Sausville E; Tan M
    Stat Med; 2008 Jul; 27(16):3071-83. PubMed ID: 18186545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and sample size for evaluating combinations of drugs of linear and loglinear dose-response curves.
    Fang HB; Tian GL; Li W; Tan M
    J Biopharm Stat; 2009 Jul; 19(4):625-40. PubMed ID: 20183430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemias.
    Shiozawa K; Nakanishi T; Tan M; Fang HB; Wang WC; Edelman MJ; Carlton D; Gojo I; Sausville EA; Ross DD
    Clin Cancer Res; 2009 Mar; 15(5):1698-707. PubMed ID: 19223502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?
    Jonker DM; Voskuyl RA; Danhof M
    Epilepsia; 2007 Mar; 48(3):412-34. PubMed ID: 17346245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and -nonspecific drugs.
    Gardner SN
    Cancer Res; 2000 Mar; 60(5):1417-25. PubMed ID: 10728708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental design and statistical analysis for three-drug combination studies.
    Fang HB; Chen X; Pei XY; Grant S; Tan M
    Stat Methods Med Res; 2017 Jun; 26(3):1261-1280. PubMed ID: 25744107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying synergism/antagonism using nonlinear mixed-effects modeling: a simulation study.
    Boik JC; Newman RA; Boik RJ
    Stat Med; 2008 Mar; 27(7):1040-61. PubMed ID: 17768754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global comparison of radiation and chemotherapy dose-response curves with a test for interaction.
    Lindstrom MJ; Kunugi KA; Kinsella TJ
    Radiat Res; 1993 Aug; 135(2):269-77. PubMed ID: 7690150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction index and different methods for determining drug interaction in combination therapy.
    Lee JJ; Kong M; Ayers GD; Lotan R
    J Biopharm Stat; 2007; 17(3):461-80. PubMed ID: 17479394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative estimation of potentiating or inhibitory effects of similarly acting drugs in combination. Advantages of a dose-response curve method over the isoboles-method (author's transl)].
    Pöch G
    Arzneimittelforschung; 1981; 31(7):1135-40. PubMed ID: 7196763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fitting models for the joint action of two drugs using SAS.
    Whitehead A; Whitehead J; Todd S; Zhou Y; Smith MK
    Pharm Stat; 2008; 7(4):272-84. PubMed ID: 17979217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo.
    Jonker DM; Visser SA; van der Graaf PH; Voskuyl RA; Danhof M
    Pharmacol Ther; 2005 Apr; 106(1):1-18. PubMed ID: 15781119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental design and sample size determination for testing synergism in drug combination studies based on uniform measures.
    Tan M; Fang HB; Tian GL; Houghton PJ
    Stat Med; 2003 Jul; 22(13):2091-100. PubMed ID: 12820275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel dose-response curves in combination experiments.
    Sühnel J
    Bull Math Biol; 1998 Mar; 60(2):197-213. PubMed ID: 9559575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of drug interactions.
    Bijnsdorp IV; Giovannetti E; Peters GJ
    Methods Mol Biol; 2011; 731():421-34. PubMed ID: 21516426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of drug combination analysis with isobolograms.
    Tallarida RJ
    J Pharmacol Exp Ther; 2006 Oct; 319(1):1-7. PubMed ID: 16670349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical analysis of drug interactions in anesthesia.
    Dexter F
    J Theor Biol; 1995 Feb; 172(4):305-14. PubMed ID: 7715200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model-based approach to the in vitro evaluation of anticancer activity.
    Del Bene F; Germani M; De Nicolao G; Magni P; Re CE; Ballinari D; Rocchetti M
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):827-36. PubMed ID: 18663447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sigmoid model versus median-effect analysis for obtaining dose-response curves for in vitro chemosensitivity testing.
    Pöch G; Vychodil-Kahr S; Petru E
    Int J Clin Pharmacol Ther; 1999 Apr; 37(4):189-92. PubMed ID: 10235422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug synergism: its detection and applications.
    Tallarida RJ
    J Pharmacol Exp Ther; 2001 Sep; 298(3):865-72. PubMed ID: 11504778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.